NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Ascelia Pharma AB (publ) (ST: ACE)

 
ACE Technical Analysis
5
As on 7th Feb 2025 ACE STOCK Price closed @ 3.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.70 & Strong Sell for SHORT-TERM with Stoploss of 3.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACESTOCK Price

Open 2.94 Change Price %
High 3.04 1 Day 0.16 5.59
Low 2.78 1 Week 0.24 8.63
Close 3.02 1 Month 0.01 0.33
Volume 856736 1 Year -0.91 -23.16
52 Week High 13.90 | 52 Week Low 2.04
 
ST Sweden Most Active Stocks
FING-B 0.01 -50.00%
S2M 0.01 0.00%
HDW-B 0.00 %
ENERS 0.00 %
SBB-B 5.34 -2.02%
ATORX 0.03 0.00%
LUNE 21.97 6.65%
QUIA 0.01 0.00%
HTRO 33.88 -13.97%
TELIA 33.50 0.00%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SECI 0.03 50.00%
SECI 0.03 50.00%
SPIFF 0.04 33.33%
GBK 2.64 22.22%
NILS 3.72 20.00%
CTM 5.00 16.55%
CTM 5.00 16.55%
CTM 5.00 16.55%
CTM 5.00 16.55%
 
ST Sweden Top Losers Stocks
FING-B 0.01 -50.00%
ADDV-B 1.32 -42.86%
ZICC 0.25 -34.21%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
AINO 0.16 -30.43%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
 
 
ACE
Daily Charts
ACE
Intraday Charts
Whats New @
Bazaartrend
ACE
Free Analysis
 
ACE Important Levels Intraday
RESISTANCE3.52
RESISTANCE3.36
RESISTANCE3.26
RESISTANCE3.16
SUPPORT2.88
SUPPORT2.78
SUPPORT2.68
SUPPORT2.52
 
ACE Forecast February 2025
4th UP Forecast6.58
3rd UP Forecast5.44
2nd UP Forecast4.73
1st UP Forecast4.03
1st DOWN Forecast2.01
2nd DOWN Forecast1.31
3rd DOWN Forecast0.6
4th DOWN Forecast-0.54
 
ACE Weekly Forecast
4th UP Forecast4.21
3rd UP Forecast3.83
2nd UP Forecast3.59
1st UP Forecast3.36
1st DOWN Forecast2.68
2nd DOWN Forecast2.45
3rd DOWN Forecast2.21
4th DOWN Forecast1.83
 
ACE Forecast2025
4th UP Forecast33.81
3rd UP Forecast23.94
2nd UP Forecast17.83
1st UP Forecast11.73
1st DOWN Forecast-5.69
2nd DOWN Forecast-11.79
3rd DOWN Forecast-17.9
4th DOWN Forecast-27.77
 
 
ACE Other Details
Segment EQ
Market Capital 942712384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACE Address
ACE
 
ACE Latest News
 
Your Comments and Response on Ascelia Pharma AB (publ)
 
ACE Business Profile
Ascelia Pharma AB (publ), a biotech company, operates as an oncology-focused orphan drug development company in Sweden. It is developing Mangoral, a novel non-gadolinium contrast agent, which is in Phase 3 for use in MRI-scans of the liver; and Oncoral, a novel oral chemotherapy tablet, which is in Phase 2 for the treatment of gastric cancer. Ascelia Pharma has a clinical collaboration agreement with Taiho Oncology, Inc. for the development of Oncoral in combination with LONSURF. The company was founded in 2000 and is headquartered in Malmö, Sweden. Address: Hyllie Boulevard 34, Malmö, Sweden, 215 32
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service